Merck & Co., Inc.
Explore Merck & Co., Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Merck & Co., Inc.
Explore Merck & Co., Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2019 Revenue
$46.8B
▲ 10.7% vs FY2018 ($42.3B)
Net Income: $9.8B
Source: 10-K
Merck & Co., Inc. reported $46.8B in revenue for fiscal year 2019. This represents a growth of 10.7% compared to the 2018 figure of $42.3B. In 2020, revenue increased to $48.0B.
Sales climbed roughly 10.7 percent year over year to about 46.8 billion USD, reflecting expanding Keytruda uptake and continued momentum across the pharmaceutical segment.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $65.0B | — | +2.2% |
| FY2024 | $63.6B | $17.1B | +5.8% |
| FY2023 | $60.1B | $365M | +1.4% |
| FY2022 | $59.3B | $14.5B | +21.7% |
| FY2021 | $48.7B | $13.0B | +1.5% |
| FY2020 | $48.0B | $7.1B | +2.5% |
| FY2019 | $46.8B | $9.8B | +10.7% |
| FY2018 | $42.3B | $6.2B | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.